Translational Platform for Immuno-Oncology Discovery

Immuno-Oncology is a rapidly growing therapeutic field that embraces the concept of modulating the immune system to recognize tumor cells and target them for destruction—by either harnessing the efforts of the immune system or preventing the evasion of tumor cells from therapeutic targeting. Charles River's platform can advance biologics and small-molecule modulators to the clinic.

Please complete the form below to download a PDF of this document: